Annual Total Liabilities
$3.04 M
+$980.70 K+47.57%
December 31, 2023
Summary
- As of February 7, 2025, ACXP annual total liabilities is $3.04 million, with the most recent change of +$980.70 thousand (+47.57%) on December 31, 2023.
- During the last 3 years, ACXP annual total liabilities has risen by +$2.52 million (+482.39%).
- ACXP annual total liabilities is now at all-time high.
Performance
ACXP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$3.32 M
+$165.90 K+5.26%
September 30, 2024
Summary
- As of February 7, 2025, ACXP quarterly total liabilities is $3.32 million, with the most recent change of +$165.90 thousand (+5.26%) on September 30, 2024.
- Over the past year, ACXP quarterly total liabilities has increased by +$95.40 thousand (+2.96%).
- ACXP quarterly total liabilities is now at all-time high.
Performance
ACXP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ACXP Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +47.6% | +3.0% |
| 3 y3 years | +482.4% | +9.9% |
| 5 y5 years | +77.8% | +9.9% |
ACXP Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +260.5% | at high | +600.3% |
| 5 y | 5-year | at high | +482.4% | at high | +600.3% |
| alltime | all time | at high | +482.4% | at high | +600.3% |
Acurx Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.32 M(+5.3%) |
| Jun 2024 | - | $3.15 M(+1.4%) |
| Mar 2024 | - | $3.11 M(+2.2%) |
| Dec 2023 | $3.04 M(+47.6%) | $3.04 M(-5.6%) |
| Sep 2023 | - | $3.22 M(+6.8%) |
| Jun 2023 | - | $3.02 M(+45.6%) |
| Mar 2023 | - | $2.07 M(+0.6%) |
| Dec 2022 | $2.06 M | $2.06 M(+74.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.18 M(+149.4%) |
| Jun 2022 | - | $473.90 K(-25.1%) |
| Mar 2022 | - | $633.00 K(-25.0%) |
| Dec 2021 | $843.90 K(+61.5%) | $843.90 K(+18.5%) |
| Sep 2021 | - | $712.40 K(-62.9%) |
| Jun 2021 | - | $1.92 M(+275.7%) |
| Mar 2021 | - | $510.70 K(-2.2%) |
| Dec 2020 | $522.40 K(-69.5%) | $522.40 K |
| Dec 2019 | $1.71 M | - |
FAQ
- What is Acurx Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals annual total liabilities year-on-year change?
- What is Acurx Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals quarterly total liabilities year-on-year change?
What is Acurx Pharmaceuticals annual total liabilities?
The current annual total liabilities of ACXP is $3.04 M
What is the all time high annual total liabilities for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high annual total liabilities is $3.04 M
What is Acurx Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, ACXP annual total liabilities has changed by +$980.70 K (+47.57%)
What is Acurx Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of ACXP is $3.32 M
What is the all time high quarterly total liabilities for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high quarterly total liabilities is $3.32 M
What is Acurx Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, ACXP quarterly total liabilities has changed by +$95.40 K (+2.96%)